BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34149431)

  • 1. Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences.
    Li J; Huang Q; Chen J; Qi H; Liu J; Chen Z; Zhao D; Wang Z; Li X
    Front Pharmacol; 2021; 12():688490. PubMed ID: 34149431
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kim HJ; Jung SW; Kim SY; Cho IH; Kim HC; Rhim H; Kim M; Nah SY
    J Ginseng Res; 2018 Oct; 42(4):401-411. PubMed ID: 30337800
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wang Z; Zhang Z; Liu J; Guo M; Li H
    J Ginseng Res; 2023 Jul; 47(4):506-514. PubMed ID: 37397417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review.
    Rajabian A; Rameshrad M; Hosseinzadeh H
    Expert Opin Ther Pat; 2019 Jan; 29(1):55-72. PubMed ID: 30513224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Compounds of
    Zhang M; Niu H; Li Q; Jiao L; Li H; Wu W
    Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256872
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives.
    Huang X; Li N; Pu Y; Zhang T; Wang B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
    J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease.
    Shin SJ; Nam Y; Park YH; Kim MJ; Lee E; Jeon SG; Bae BS; Seo J; Shim SL; Kim JS; Han CK; Kim S; Lee YY; Moon M
    Free Radic Biol Med; 2021 Feb; 164():233-248. PubMed ID: 33422674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms.
    Chen J; Huang Q; Li J; Yao Y; Sun W; Zhang Z; Qi H; Chen Z; Liu J; Zhao D; Mi J; Li X
    J Ethnopharmacol; 2023 Jan; 300():115715. PubMed ID: 36108895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginseng gintonin, aging societies, and geriatric brain diseases.
    Choi SH; Lee R; Nam SM; Kim DG; Cho IH; Kim HC; Cho Y; Rhim H; Nah SY
    Integr Med Res; 2021 Mar; 10(1):100450. PubMed ID: 32817818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Ginseng for the Treatment of Alzheimer's Disease: A Review.
    Shan M; Bai Y; Fang X; Lan X; Zhang Y; Cao Y; Zhu D; Luo H
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gintonin: a novel ginseng-derived ligand that targets G protein- coupled lysophosphatidic acid receptors.
    Nah SY
    Curr Drug Targets; 2012 Dec; 13(13):1659-64. PubMed ID: 23017203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective.
    Jin D; Zhang Y; Zhang Y; Duan L; Zhou R; Duan Y; Sun Y; Lian F; Tong X
    Front Pharmacol; 2021; 12():734151. PubMed ID: 34512359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders.
    Ikram M; Ullah R; Khan A; Kim MO
    Cells; 2020 Jun; 9(6):. PubMed ID: 32549286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Neuroprotective Effects and Mechanisms of Ginsenosides From Panax Ginseng in Treating Ischemic Stroke.
    Zhao A; Liu N; Yao M; Zhang Y; Yao Z; Feng Y; Liu J; Zhou G
    Front Pharmacol; 2022; 13():946752. PubMed ID: 35873557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.
    Tripathi PN; Lodhi A; Rai SN; Nandi NK; Dumoga S; Yadav P; Tiwari AK; Singh SK; El-Shorbagi AA; Chaudhary S
    Degener Neurol Neuromuscul Dis; 2024; 14():47-74. PubMed ID: 38784601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of ginseng on neurological disorders.
    Ong WY; Farooqui T; Koh HL; Farooqui AA; Ling EA
    Front Aging Neurosci; 2015; 7():129. PubMed ID: 26236231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin.
    Im DS; Nah SY
    Acta Pharmacol Sin; 2013 Nov; 34(11):1367-73. PubMed ID: 24122014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).
    Razgonova MP; Veselov VV; Zakharenko AM; Golokhvast KS; Nosyrev AE; Cravotto G; Tsatsakis A; Spandidos DA
    Mol Med Rep; 2019 Apr; 19(4):2975-2998. PubMed ID: 30816465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease.
    He S; Shi J; Chai H; Ma L; Pei H; Zhang P; Shi D; Li H
    Heliyon; 2024 Mar; 10(5):e26642. PubMed ID: 38434355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.